Clients have come to depend on our comprehensive knowledge of the public and private healthcare sectors and an in-depth understanding of the field’s multifaceted and diverse nature. Such is our sophisticated advice and unswerving commitment to the sector, we represent all types of health clients – from healthcare providers, start-ups and established companies, suppliers and clients in pharmaceutical, medical devices, biotechnology and the hot topic of medical cannabis – an area in which we have accumulated vast experience.
Our Rolls Royce service is valued by the most illustrious clients in the market – among them Clalit Health Services, the largest Health Maintenance Organization (HMO) in the country and the second largest healthcare provider in the world, as well as its many subsidiaries (Mor – the Institute for Medical Information Ltd., S.L.H. Health Services Ltd., Clalit Medical Engineering Ltd., Tel-Bar Industries for Health Institutions Ltd., Mor-Mar Diagnostic Imaging Ltd., and Mor Research Applications Ltd., the Clalit Group’s technology transfer company).
Furthermore, we have developed special expertise in group health insurance in general and in collective long-term care insurance in particular, and handle all aspects of the collective long-term care insurance for members of Clalit, covering more than 1.8 million insured members.
In addition to their day-to-day commercial needs, such clients turn to Lipa Meir & Co. for the complete gamut of advice, including financing, healthcare mergers and acquisitions, commercial and licensing agreements, clinical and other trial agreements, R&D agreements, agreements for collaborations with medical institutions, universities and research entities, manufacturing agreements, distribution agreements, administrative and regulatory issues, occupational health and safety regulations, insurance law, intellectual property, litigation, class actions, as well ethical questions, the right of patients to privacy, pharmaceutical and device manufacturers, and much more.
As such, clients are reassured by this substantial experience, which allows us to translate the complexities of the law, the legislative process and reforms to ensure they achieve their objectives in a cost-effective and timely manner.
News & Publications
14.04.22
Digital Health In Israel – The Upsurge Of Big Data & Preemptive Medicine: The Role Of The Public Sector
US Israel Legal Review
In this era of massive global interest in the potential of AI and digital health, investments in the digital health field exceeded $20 billion in less than a six-month period in 2021 alone. The future of this sector is seen by many experts to hinge on utilizing and mastering Big Data and AI capabilities for algorithmic […]
20.05.21
Lipa Meir & Co. is hugely proud and would like to congratulate our partner and Head of International Department, Gary Copelovitz, who has won “Corporate Lawyer of the Year”
Lipa Meir & Co. is hugely proud and would like to congratulate our partner and Head of International Department, Gary Copelovitz, who has won “Corporate Lawyer of the Year” at this year’s LMG’s Life Sciences Legal Awards in Europe. LMG Life Sciences Awards Researcher John Harrison said of Gary’s win: “He is well-known for his […]
11.04.21
LMG Life Sciences
Awards 2021
Lipa Meir is shortlisted in the LMG Life Sciences Awards 2021 for Israel’s Life Sciences Law Firm of the Year, as well as in the category of Corporate Law Firm of the Year (Europe)! In addition, Head of our International Department, Gary Copelovitz, is shortlisted for Corporate Lawyer of the Year (Europe). Part of the seasoned […]
19.10.20
Israeli animal health co Mileutis raises $20m
Globes
Mileutis is in advanced stages of development of an innovative product which addresses bovine mastitis, the main concern in the dairy industry. Israeli animal health company Mileutis Ltd. has received a $20 million investment from US life sciences and healthcare investor NovaQuest Capital Management LLC, as part of a product financing agreement. Ness Ziona-based Mileutis […]
21.07.20
FutureMed 2020 – Online Conference
FutureMed 2020
The first wave of the CoronaVirus pandemic has hit every sphere of public and private life. Different governments have presented different approaches, all of which have been asked to plan and adopt health management and new regulations on the move, while no one has an unequivocal answer to the key question: What is the right […]
16.04.20
The Legal 500 Europe, Middle East & Africa 2020 rankings released
Lipa Meir & Co has been recommended as a TOP-TIER FIRM in 3 practice areas: – Energy – Healthcare and life sciences – Restructuring and insolvency Lipa Meir & Co has also been recommended in the following 13 practice areas: – Banking and finance – Capital markets – Commercial, corporate and M&A – Competition antitrust […]
28.01.19
Israeli Medical Cannabis Export
Client Update
Yesterday, the Israeli cabinet approved the long-awaited export of medical cannabis from Israel. The Israeli cabinet decided to permit export of medical cannabis products to countries that accepted the Single Convention on Narcotic Drugs of 1961 and willing to import medical cannabis from Israel. Export of medical cannabis products will be permitted, but no plants, […]
